ABN AMRO spins out life sciences group

ABN AMRO Capital has spun out its life sciences venture arm, which operates a €200m life sciences fund, focused on the US and Europe.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this